CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,040 enrolled
Drug / intervention
Transmission of sFlt-1 results to the investigator +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00763672
NCT00763672N/ACompleted
CompareCT.gov

Impact of a Single Second-trimester Plasma sFlt-1 and/or Urinary PlGF Assay on Maternofetal Morbidity/Mortality

Assistance Publique - Hôpitaux de Paris·interventional·Posted Oct 1, 2008·Updated Mar 28, 2013

In Brief

A clinical study evaluating Transmission of sFlt-1 results to the investigator and No transmission of the sFlt-1 results to the investigator for Pregnancy and 4 related conditions. Completed, enrolled 1,040 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether close monitoring of patients with a high sFlt1 plasma level between 25 and 28 weeks of gestation (i.e. at high risk of subsequent preeclampsia) improves maternal and fetal outcomes. The investigator hypothesize that 1/ early screening for preeclampsia by plasmatic sFlt1 will reduce maternal and fetal mortality and morbidity and 2/ a simple urinary PlGF screening will be effective.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy, Primiparity, Hypertension, Preeclampsia, Intrauterine Growth Retardation
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 1, 2008
Enrollment StartNov 1, 2008
Primary CompletionMay 1, 2011
Study CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 17.8 years ago

Interventions

Transmission of sFlt-1 results to the investigatorother

Transmission of sFlt-1 results by the laboratory to the investigator

No transmission of the sFlt-1 results to the investigatorother

The laboratory do not transmit the sFlt-1 results to the investigator before the end of the study.